NeuroOne Medical Technologies Corporation (NMTC)Healthcare | Medical Devices | Eden Prairie, United States | NasdaqCM
1.77 USD
-0.21
(-10.606%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.68 -0.09 (-0.090%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 1:05 a.m. EDT
The investment case for NeuroOne is currently broken by a catastrophic multi-year decline. Despite recent positive headlines regarding FDA clearance and insider buying, the price action tells a different story: the stock has lost 96% of its value over the last seven years, with every single year showing negative returns. This is not a temporary setback; it is a structural implosion where the market has repeatedly rejected the business model. Fundamentally, the company is bleeding cash with negative operating margins, negative free cash flow, and a forward P/E that indicates no expected earnings. While the balance sheet shows low debt relative to equity, the relentless 7-year streak of declining prices and shrinking revenue growth demonstrates that the market views the current operations as insufficient to sustain value. The recent reverse stock split and insider purchases are likely defensive maneuvers to maintain compliance and morale rather than signs of a turnaround. With no dividend to provide income and a statistical forecast leaning negative, the risk-reward profile remains severely skewed toward further downside. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.192873 |
| AutoETS | 0.209959 |
| MSTL | 0.212600 |
| AutoTheta | 0.266568 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 5.72 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.099 |
| Excess Kurtosis | -1.54 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.654 |
| Revenue per Share | 1.472 |
| Market Cap | 16,117,200 |
| Forward P/E | -6.32 |
| Beta | 0.64 |
| Profit Margins | -59.71% |
| Website | https://nmtc1.com |
As of Aug. 22, 2026, 1:05 a.m. EDT: Speculators are overwhelmingly bearish, with zero call volume and open interest across all expirations compared to significant put activity concentrated at strikes of 2.5, 5.0, and 7.5. This heavy positioning in downside protection suggests a strong expectation of further price weakness or a desire to hedge against continued deterioration.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.54230237 |
| Address1 | 7,599 Anagram Drive |
| All Time High | 180.0 |
| All Time Low | 1.423 |
| Ask | 2.27 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 1,436,850 |
| Average Daily Volume3 Month | 274,566 |
| Average Volume | 274,566 |
| Average Volume10Days | 1,436,850 |
| Beta | 0.637 |
| Bid | 1.83 |
| Bid Size | 1 |
| Book Value | 0.433 |
| City | Eden Prairie |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.77 |
| Current Ratio | 2.836 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.95 |
| Day Low | 1.71 |
| Debt To Equity | 4.654 |
| Display Name | NeuroOne Medical |
| Earnings Call Timestamp End | 1,786,624,200 |
| Earnings Call Timestamp Start | 1,786,624,200 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,786,624,200 |
| Earnings Timestamp Start | 1,786,624,200 |
| Ebitda | -7,663,002 |
| Ebitda Margins | -0.61458 |
| Enterprise To Ebitda | -1.859 |
| Enterprise To Revenue | 1.142 |
| Enterprise Value | 14,244,950 |
| Eps Forward | -0.28 |
| Eps Trailing Twelve Months | -0.87 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.3171 |
| Fifty Day Average Change | -0.54710007 |
| Fifty Day Average Change Percent | -0.23611413 |
| Fifty Two Week Change Percent | -54.230236 |
| Fifty Two Week High | 6.96 |
| Fifty Two Week High Change | -5.19 |
| Fifty Two Week High Change Percent | -0.74568963 |
| Fifty Two Week Low | 1.423 |
| Fifty Two Week Low Change | 0.347 |
| Fifty Two Week Low Change Percent | 0.24385102 |
| Fifty Two Week Range | 1.423 - 6.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,521,120,600,000 |
| Float Shares | 6,271,776 |
| Forward Eps | -0.28 |
| Forward P E | -6.3214283 |
| Free Cashflow | -4,566,159 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | -0.21 |
| Fullday Change Percent | -10.6061 |
| Fullday Price | 1.68 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.23005 |
| Gross Profits | 2,868,413 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.25229 |
| Held Percent Institutions | 0.22447 |
| Implied Shares Outstanding | 9,105,763 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-05-26 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,759,190,400 |
| Last Split Date | 1,776,297,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota. |
| Long Name | NeuroOne Medical Technologies Corporation |
| Market | us_market |
| Market Cap | 16,117,200 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_412033082 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -7,445,464 |
| Next Fiscal Year End | 1,790,726,400 |
| Non Diluted Market Cap | 18,029,410 |
| Number Of Analyst Opinions | 3 |
| Open | 1.89 |
| Operating Cashflow | -7,052,007 |
| Operating Margins | -1.22868 |
| Payout Ratio | 0.0 |
| Phone | 952 426 1383 |
| Post Market Change | -0.09000003 |
| Post Market Change Percent | -5.084748 |
| Post Market Price | 1.68 |
| Post Market Time | 1,787,961,598 |
| Previous Close | 1.98 |
| Price Hint | 4 |
| Price To Book | 4.08776 |
| Price To Sales Trailing12 Months | 1.2926111 |
| Profit Margins | -0.59713 |
| Quick Ratio | 1.541 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | -0.21 |
| Regular Market Change Percent | -10.6061 |
| Regular Market Day High | 1.95 |
| Regular Market Day Low | 1.71 |
| Regular Market Day Range | 1.71 - 1.95 |
| Regular Market Open | 1.89 |
| Regular Market Previous Close | 1.98 |
| Regular Market Price | 1.77 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 460,050 |
| Return On Assets | -0.58068 |
| Return On Equity | -1.24662 |
| Revenue Growth | 0.163 |
| Revenue Per Share | 1.472 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 9,105,763 |
| Shares Percent Shares Out | 0.009 |
| Shares Short | 82,079 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 12,127 |
| Short Name | NeuroOne Medical Technologies C |
| Short Percent Of Float | 0.0093 |
| Short Ratio | 1.28 |
| Source Interval | 15 |
| State | MN |
| Symbol | NMTC |
| Target High Price | 8.8 |
| Target Low Price | 5.0 |
| Target Mean Price | 7.26667 |
| Target Median Price | 8.0 |
| Total Cash | 2,047,596 |
| Total Cash Per Share | 0.225 |
| Total Debt | 175,345 |
| Total Revenue | 12,468,715 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.87 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.904745 |
| Two Hundred Day Average Change | -2.1347451 |
| Two Hundred Day Average Change Percent | -0.54670537 |
| Type Disp | Equity |
| Volume | 460,050 |
| Website | https://nmtc1.com |
| Zip | 55,344 |